Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03182075 · ClinicalTrials.gov registry record · NA

Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT03182075: Completed NA study, sponsored by Stanford University.

NCT03182075 is a NA study that has completed, run by Stanford University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03182075, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Obsessive-Compulsive Disorder (OCD) is a chronic and disabling disorder that costs the economy over $2 billion annually and represents a significant public health problem. This study aims to build on our understanding of aberrant emotional processing in OCD. The proposed project tests whether a computerized training aimed to alter emotional processes, can relieve repetitive thoughts and behaviors.

Primary Outcome

Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.

Interventions

  • BEHAVIORAL Computerized Training

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-04-30
Est. Completion 2018-11-12
Phase NA
Stanford University

1,744 total trials

What the finished NCT03182075 record still lists

NCT03182075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Computerized Training is the first listed.

NCT03182075 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03182075 about?

NCT03182075 is a clinical study titled "Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders". Obsessive-Compulsive Disorder (OCD) is a chronic and disabling disorder that costs the economy over $2 billion annually and represents a significant public health problem. This study aims to build on our understanding of aberrant emotional processing in OCD. The proposed project tests whether a comp...

What is the current status of trial NCT03182075?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-04-30. Estimated completion is 2018-11-12.

What interventions are being tested in trial NCT03182075?

The interventions under investigation include: Computerized Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03182075?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03182075's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03182075, the US trial registry maintained by the National Library of Medicine. NCT03182075 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.